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54 The Journal of Thoracic and Cardiobjectives: Implanting expanded polytetrafluoroethylene neochordae is an estab-
ished technique in treating complex mitral regurgitation. Difficulty in obtaining
eliable preoperative and intraoperative measurements of an ideal neochordae
ength, as well as the unfeasibility of adjusting lengths once set in place with
raditional techniques, led us to develop a system that allows rapid change of length
fter the evaluation of valve continence with hydrostatic tests.
ethods: The system consists of two components: a papillary component with arrest
nots at constant intervals and a leaflet component with a reversible noose-lace to fix the
oop to 1 of the knots on the papillary component. After implantation and coupling of
he two components at a presumable optimal length, a prosthetic ring is sutured in place.
ydrostatic testing is then performed. Optimal chordae length can be obtained by
eleasing the noose-lace and sliding it over another fixing-knot. The adjustment can be
erformed as often as required without placing stress on the anatomic structures.
esults: Twenty patients underwent repair with this technique. No deaths or major
dverse events occurred. All patients underwent echocardiography, both at dis-
harge and 6 months after the operation. A total of 14 patients had no residual
nsufficiency, 5 patients had mild or trivial postoperative insufficiency without
rogression of regurgitation at the sixth month, and only 1 patient had mild
nsufficiency at discharge progressing to moderate insufficiency at the sixth month.
onclusion: This new technique facilitates an otherwise complicated procedure.
hort-term results are satisfactory, but further follow-up is required.
itral valve chordae tendineae replacement with expanded polytetrafluo-
roethylene (ePTFE) sutures is an established technique for mitral valve
repair.1 Artificial chordae have been successfully used in large series 
xcellent long-term results.2,3
Attempts to replace chordae, however, can be frustrated by difficulties encoun-
ered both in determining the optimal length of ePTFE sutures and in fixing them to
alve leaflets and papillary muscles. Chordal length can be anticipated by echocar-
iography4 or by referring to healthy segments of the valve5; both methods suffe
pproximation because they lack a fixed and objective reference point. Experience
nd surgical skills are required to achieve optimal results. Moreover, expanded
PTFE sutures are slippery, and often knot tying can result in longer or shorter than
lanned neochordae. If intraoperative tests show that neochordae length is inappro-
riate, there is no other technical option but to replace them.6
We developed a configuration of polytetrafluoroethylene (Gore-Tex; WL Gore &
ssociates, Inc, Flagstaff, Ariz) sutures by which the length of artificial chordae can
e readjusted, as many times as required, without touching their papillary or leaflet
nchoring, before fixing them in a definitive position. Our technique is described
nd preliminary experience is reported.
vascular Surgery ● August 2007
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CDaterials and Methods
opulation
rom October 1, 2004, to November 1, 2006, 20 patients (eight
ale, mean age 60.2  9.1 years) underwent mitral valve repair
rocedure with artificial chordae implantation after acquiring in-
ormed consent. Only patients with no need for concomitant pro-
edures were included in the study. The patients’ characteristics,
ntraoperative findings, details regarding techniques used, and re-
ults are illustrated in Table 1.
urgical Technique
ur method for mitral chordae replacement is based on reversible
oupling of two ePTFE components: the leaflet component and the
apillary component.
The leaflet component is achieved with a CV-5 polytetrafluo-
oethylene (Gore-Tex) suture. A circular loop is obtained at the
iddle of the suture by tying it around a Hegar dilator with a
iameter of 13 mm. When the loop is flattened, its length equals
alf the circumference. Given a circumference of approximately 4
m for a circle with a diameter of 13 mm, the final length of the
Abbreviations and Acronyms
ePTFE expanded polytetrafluoroethylene
ABLE 1. Population characteristics
atients
ale/female
ge, y
jection fraction (mean)
itral valve lesions
P2 flail 7
A2 prolapse 5
A3-P3 prolapse 3
A2-P2 prolapse (Barlow) 2
otal No. of chordae implanted
Anterior leaflet 29
Posterior leaflet 33
ostimplant length-adjustment maneuvers
ssociate procedures
Ring annuloplasty
P2 resection
P2 resection  sliding technique
Suture of clefts
Ring size (mm)
PB time (min)
ortic crossclamp time (min)
U time (mo)
MR at d
one 1
 or trivial

 or morePB, Cardiopulmonary bypass; FU, follow-up; MR, mitral regurgitation. See text
The Journal of Thoracicoop will be approximately 2 cm (Figure 1). The papillary 
onent is obtained by cutting a CV-4 polytetrafluoroethylene
Gore-Tex) suture in two halves. After this, 5 double surgeon’s
nots, at a fixed distance of 2 mm, are placed at the needleless tip
f each CV-4 semisuture. To facilitate correct positioning of the
nots, the needleless tip of the suture is anchored on a drape, knots
re made with the help of forceps and a needle holder, and then,
iven the slippery properties of the ePTFE fabric, slid into defin-
tive position by inserting the tip of the needle or a nerve hook in
he knot itself. Two CV-4 half sutures with knots are needed to
ealize the papillary component of each neochorda (Figure
hordae components are achieved during preparation for cardio-
ulmonary bypass.
After assessment of the mitral valve lesions, the papillary
omponent is set in place first by fixing 2 semisutures to a papillary
ead and tying on the sutures so that the papillary head is “sand-
iched” between 2 ePTFE pledgets to reduce trauma (Figur
utures are left inside the ventricle. Two CV-5 loops are then fixed
n the desired leaflet, 2 to 3 mm apart from the leaflet’s edge,
assing the needle from the atrial to the ventricular side and
eaving knots on the ventricular aspect of the leaflet. A single
PTFE pledget is interposed on the atrial side (Figure 1).
To achieve reversible coupling of the leaflet component with
he papillary component of the neochorda, a loop that can be
ightened and loosened as many times as required is placed in the
eaflet component with the help of forceps and a curved instrument
9.1
6.6
ail  A2 prolapse 1
1 prolapse 1
ail 1
ean 3.1 1.0 per patient)
ordae on A2 and 3 chordae on A3
rda on P1, 29 chordae on P2, and 3 chordae on P3
ean 3.3 1.6 per patient)
2.2
27
19
6
rge MR at latest FU
14
5
1
020
8/12
60.2
61.3
P2 fl
A1-P
P1 fl
62 (m
26 ch
1 cho
67 (m
19
2
1
3
31.6
83
66
17
ischa
4
6
0
0for description of the techniques.
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A
CDFigure 2). The papillary component is then passed inside the 
nd the loop is tightened; the loop has to fall in the gap between
wo knots. The chordal length is fixed by closing the loop under the
elected reference knot of the papillary component (Figure 3).
aneuver is repeated for the other chordae. To shorten or
longate the neochorda without touching its papillary or leaflet
nchoring, the loop is released (to release the joint between the
components, the tip of the discarded CV-5 suture needle is
nserted inside the loop and the leaflet component is opened),
lid under a reference knot respectively closer or farther from
igure 1. The papillary component (down) is fixed at the papillary
uscle head. ePTFE pledgets are used to reduce trauma. The
eaflet component (up) is fixed at the desired portion of the mitral
alve leaflet, leaving knots on the ventricular side.he papillary muscle tip, and tightened again. s
56 The Journal of Thoracic and Cardiovascular Surgery ● Augu,
Competence of the mitral valve is checked by saline infusion
nto the left ventricle. Even if the lengths of all the chordae have
o be changed, that can be easily achieved at this time. When a
atisfactory result is achieved, the loop is closed by firmly pulling
he two components in opposite directions, and the excess length
f the papillary component is trimmed.
To evaluate the static properties of the new configuration and
ts failure load in comparison with the standard procedure, the
rtificial chordae were loaded in an uniaxial machine (Instron
542, Norwood, Mass; load cell of 50N) and strains were calcu-
ated by an optical extensometer: The images were recorded by a
amera (Nikon Coolpix 4500, Tokyo, Japan) during the tests and
nalyzed with a specific Matlab code (The MathWorks Inc, Natick,
ass), referring to ink-colored markers positioned along the
utures.
ollow-up
systematic mitral valve analysis was carried out intraoperatively
nd at 6 months follow-up by transesophageal echocardiography
sing a Sonos 5005 echocardiograph (Hewlett Packard, Andover,
ass) equipped with a Philips T6210 omniplane transesophageal
chocardiography probe (Philips, Bothell, Wash). Valve lesions
ere categorized according to Carpentier’s classification.7 Grading
f residual mitral regurgitation is reported according to indications
f the American Society for Echocardiography.8
esults
ur technique was successful in all patients. All patients
igure 2. A loop is created on the implanted leaflet component by
ulling the free end with forceps and folding it by 180 degrees;
his maneuver creates 2 small rings. The papillary component is
hen passed inside both rings, and coupling is attained by closing
he loop and pulling the 2 components in opposite directions. The
ourse of the papillary component inside the loop (black line).urvived. No complications were reported in the in-hospital
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A
CDostoperative course except for 3 patients (15%) who ex-
erienced paroxysmal atrial fibrillation treated by amioda-
one infusion. Patients in sinus rhythm received only anti-
latelet drugs; anticoagulation was reserved for patients
xperiencing atrial fibrillation. No neurologic events were
eported. No major events were reported at 6 months
ollow-up. Regurgitation grade was stable except for a sin-
le patient who experienced a worsening of mitral regurgi-
ation from 1 to 2, not apparently related to chordal
ehiscence. In this patient, flail P1 and P2 segments of the
osterior leaflet and massive annular calcification were ob-
erved at operation and treated by positioning two leaflet
omponents: one on P1 and one on P2. An annuloplasty ring
as not implanted because of massive annular calcifica-
ions. No instances of neochordae rupture were documented
t follow-up.
iscussion
olutions proposed to adjust the length of ePTFE chordae
uring mitral valve repair surgery can be grouped in two
ajor categories.
In the first group of techniques, artificial chordae are first
utured on the papillary muscle tip and then on the mitral
alve leaflets; knot tying is deferred after open heart mitral
alve competence tests have shown an effective coaptation.
A method to adjust chordal length was described by
evuelta and colleagues9 in a sheep model. A doub
igure 3. The papillary component is passed inside the leaflet
omponent, and the loop is tightened just below the desired knot.
he loop can be loosened and repositioned as many time as
eeded to achieve a perfect valve competence. Once the result is
onsidered satisfactory, the exceeding portion of the ventricular
omponent is cut and discarded.rmed, pledget-supported ePTFE suture was passed through p
The Journal of Thoraciche anterior papillary muscle and then woven into the mitral
eaflet from the edge toward the annulus where it was
rought out and passed through a second pledget. Valve
ompetence was obtained by pulling on the ePTFE suture
hile filling the left ventricle with blood through the apical
ent. Suture length was fixed by tying at that time. Kas-
gawa and colleagues6 reported the use of small tourniqu
o adjust the length of artificial chordae, during open mitral
alve competence testing, before definitive knot tying. In
he method described by Adams and coworkers,10 a double-
rmed 4-0 ePTFE suture is passed as a simple suture into the
ead of the papillary muscle and left aside while leaflet
econstruction is performed. After ring annuloplasty, both
rms of the suture are passed twice through the prolapsing
ortion of the leaflet and tied starting with a surgeon knot
fter valve competence has been achieved with saline in-
ections into the left ventricle.
These methods are obviously independent of echocar-
iography or intraoperative measurements and are free
rom errors that can be induced by using “healthy seg-
ents” of the valve as reference points. The final results
an be significantly affected by knot tying and eventual
not sliding.
To set the length of neochordae and to avoid the effect of
not tying on the suture’s length, Sarsan11 proposed placing
temporary edge-to-edge suture that is removed only after
not tying, between the normal and prolapsing facing por-
ions of the mitral valve. Rankin and colleagues12 recently
roposed a technique to attain adjustable chordae: Sutures
re first passed through the head of the papillary muscle
reviously reinforced by “sandwiching” it between two
ledgets and then, after positioning the annuloplasty ring,
hrough the leaflet. A slipknot is attained and temporarily
xed with a clip. If competence tests fail, the clip is re-
oved and knot slipped by 1-cm increments until a satis-
actory competence is achieved. Eight more knots are tied
n the clip that is subsequently removed. With this tech-
ique, the chordal length is fully adjustable and not affected
y knot tying.
A second group of techniques relies on the creation of
remeasured ePTFE loops or on devices that measure
hordal length and avoid knot migration at the same time.
Von Oppel and Mohr13 described a method to atta
remeasured chordae by referring to nonprolapsing seg-
ents of the valve. Premeasured loops are fixed on the
apillary muscle and then by a second suture on the desired
egment of the leaflet. Matsui and coworkers14 introduced a
evice to measure chordae of normal valve segments and to
top knots during knot tying. These methods eliminate the
otentially deleterious effect of knot tying. The final length
f artificial chordae, however, is entirely dependent on
reoperative or intraoperative measurements.
and Cardiovascular Surgery ● Volume 134, Number 2 457
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A
CDAll the techniques described share a theoretic limit: If the
nal length is incorrect, artificial chordae have to be re-
oved and replaced. This can result in weakening of pap-
llary muscles and mitral valve leaflets and can determine a
ignificant prolongation of myocardial ischemic time. If
nappropriate chordal length becomes apparent after an an-
uloplasty ring has been positioned, it can be impractical to
mplant new chordae with the ring in place.
Our technique eliminates the need to premeasure chordae
y echocardiography and to refer to “healthy” segments of
he valve. The surgeon simply needs to connect the two
omponents to leaflet and papillary muscle to attain cou-
ling. Because the papillary and leaflet components are
xed before coupling, the effect of knot-tying maneuvers on
he final chordae length is eliminated. Artificial chordae
ength can be adjusted, without repositioning sutures on
itral valve leaflets or papillary muscles, as often as re-
uired. Length adjustment can be attained even if a pros-
hetic ring is already in place. Because adjustment steps are
ocated only 2 mm apart, our technique results in effective
ne-tuning and customization of chordal length.
In our preliminary experience, 67 chordal length-
djustment maneuvers were performed on 62 implanted
hordae. That is, all chordae in question had an incorrect
ength at the first coupling or the technique led to multiple
ttempts, occasionally resulting in overcorrection (22 of
hese maneuvers were made to return to the previous
ength). This demonstrates the relative utility of the system.
A series of steps were followed, consisting primarily of
mplanting the papillary components, followed by placing
nnular sutures for ring positioning. Leaflet reconstruction
s then performed if required, followed by the implantation
f the leaflet components. Coupling, tests, and adjustment
aneuvers are performed only after positioning the annu-
oplasty ring. This sequence, postponing chordal set-up after
ing positioning (which almost always affects the quality
nd extent of mitral leaflet coaptation), is significantly
ime-saving.
One potential limitation of the technique is that knots
ade on the papillary component to stop the closed loop of
he leaflet component could slide under tension, and this
ould result in chordal elongation or opening of the system.
echanical properties of the new suture configuration have
ABLE 2. Tensile strength of CV4 size tested with and
ithout knots at the two different test rates
Maximum load (N)
Suture 2 mm/min 10 mm/min
Simple 10.9 0.3 13.6 0.6
Knotted 10.5 0.6 14  0.7een thoroughly investigated by us.15 Tensile tests revealed
58 The Journal of Thoracic and Cardiovascular Surgery ● Auguhat knots do not significantly affect the strength of the
uture; in fact, simple and knotted sutures reached similar
ltimate loads (Table 2). Adjustable-length chordae exh
kind of perfect plastic behavior with rather high strains at
upture; their static properties are comparable to the stan-
ard technique (Table 3).
A second limitation is the possibility that the loop on the
eaflet component could open spontaneously in an eventual
epowered situation in which chordae are not under tension.
owever, in the early 1960s while studying chordae tendi-
eae tension, Salisbury and colleagues16 demonstrated that
he diastolic tension on chordae tendineae, in the nonfailing
eart with the pericardium closed, is never less than 12 g.
his means that human chordae tendineae do have a relative
esting phase but are always under tension. This is reflected
n our clinical experience in which no instances of failure or
pening of the system could be documented at follow-up.
With our system, a continuous adjustment of chordal
ength is not possible. Length adjustment depends on the
xed distance of 2 mm between knots on the papillary
omponent. This is a potential limitation in cases in which
fine-tuning of chordal length is desired. In our initial
linical experience, however, results were encouraging.
onclusions
his new technique to determine the proper length of mitral
eochordae has the advantage of easily correcting for small
rrors when judging the optimal length of the neochordae. A
imple modification in the point of coupling of the two
hordae components precludes the need to repeat the whole
urgical procedure. Although further follow-up is required,
arly clinical results are promising. The possibility of hav-
ng premanufactured artificial chordae as described would
reatly facilitate their use.
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